In this Section |
217490 Changing Patterns in Health Behaviors and Risk Factors Related to Cardiovascular Disease Among American Indians and Alaska NativesTuesday, November 9, 2010
Objectives. We assessed changes in cardiovascular disease–related health behaviors and risk factors among American Indians and Alaska Natives by age and gender. Methods. We used cross-sectional data from the 1995 to 1996 and the 2005 to 2006 Behavioral Risk Factor Surveillance System. The respondents were 2548 American Indian and Alaska Native women and men aged 18 years or older in 1995–1996 and 11|104 women and men in 2005–2006. We analyzed the prevalence of type 2 diabetes, obesity, hypertension, cigarette smoking, sedentary behavior, and low vegetable or fruit intake. Results. From 1995–1996 to 2005–2006, the adjusted prevalence of diabetes among American Indians and Alaska Natives increased by 26.9%, from 6.7% to 8.5%, and obesity increased by 25.3%, from 24.9% to 31.2%. Hypertension increased by 5%, from 28.1% to 29.5%. Multiple logistic models showed no meaningful changes in smoking, sedentary behavior, or intake of fruits and vegetables. In 2005–2006, 79% of the population had 1 or more of the 6 unhealthy behaviors or risk factors, and 46% had 2 or more. Conclusions. Risk factors associated with diabetes, obesity, and hypertension among urban, rural, and reservation American Indian and Alaska Native populations should be studied further, and effective primary and secondary prevention efforts are critical.
Learning Areas:
Chronic disease management and preventionEpidemiology Learning Objectives: Keywords: Indigenous Populations, Chronic Diseases
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I oversea diabetes and CVD programs for Native Americans as a postdoctoral fellow at Stanford and now Assistant Professor at the University of Washington. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4320.0: Cardiovascular disease and diabetes epidemiology poster session
|